Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
:
Association of glucagon-like peptide-1 receptor agonist vs dipeptidyl peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced chronic kidney disease
Cleveland Clinic explains that GLP-1 agonists can make food stay in the stomach longer and reduce appetite, but they can also cause digestive side effects like nausea and constipation, which makes food choices more important
(c) traditional PA is manual and burdensome, but ePA is emerging to address these issues through digital workflows
Patients with certain variants may experience stronger appetite suppression at lower doses, while others require higher doses to achieve the same effect
10.1042/bj3360001 333 WuG.SharinaI.MartinE
US$ 27.43
US$ 29.37
US$ 27.56
US$ 23.55
